1. From Science Labs to Smartphones
It wasn’t long ago that vagus nerve stimulation meant hospital procedures and implanted electrodes. Now, it’s wearable, wireless, and as simple as putting on a headset.
Pulsetto, launched from Europe in 2022, helped make that leap mainstream. The company’s promise is direct: reset your nervous system and reduce stress in minutes - no surgery, no medication.
ZenBud, meanwhile, represents the next technical evolution of the same idea. Instead of electrical pulses, it uses ultrasound waves to stimulate the vagus nerve - achieving the same biological goal through smoother, deeper physics.
Both devices are part of a growing revolution: turning stress relief into a measurable science.
2. What Pulsetto Does
Pulsetto is a transcutaneous electrical nerve stimulation (tVNS) device. It delivers mild electrical impulses through two electrodes placed on the side of the neck, targeting the cervical branch of the vagus nerve.
The user pairs it with a mobile app that offers programs for “Relax,” “Sleep,” “Recover,” and “Focus.” Each mode changes pulse width and frequency to modulate the nerve differently.
The sensation is familiar to anyone who’s tried electrical muscle stimulation - a mild tingling shock or buzz. Sessions last 6–10 minutes, and users typically report feeling calmer, lighter, or drowsy within minutes.
The company has published internal pilot studies showing reductions in perceived stress and improvements in HRV (heart-rate variability), though these are not yet peer-reviewed.
Pulsetto’s great achievement is accessibility: bringing basic vagus-nerve science to thousands of new users at an approachable price point.
3. What ZenBud Does
ZenBud uses ultrasound instead of electricity.
Inside each earpiece is a miniature transducer that emits focused acoustic waves in the MHz range. Those waves penetrate skin and cartilage to stimulate the auricular branch of the vagus nerve (ABVN) - the same neural circuit used in clinical implanted VNS systems, but without surgery or shock.
Ultrasound activates mechanosensitive ion channels rather than forcing current through tissue. That means no tingling, no gels, no electrical artifacts - just comfortable, precise stimulation.
In a peer-reviewed trial (JMIR Neuro, 2025), daily 5-minute ZenBud sessions produced 78.6 % remission of clinical anxiety, with significant improvements in HRV and mood scores.
It’s the same destination as Pulsetto - vagal activation - but achieved with higher signal fidelity and clinical backing.
4. The Physics Compared
| Aspect | Pulsetto | ZenBud |
|---|---|---|
| Mechanism | Electrical tVNS | Ultrasound uVNS |
| Primary Target | Cervical vagus nerve | Auricular vagus nerve (ABVN) |
| Energy Type | Electric current (Hz range) | Acoustic waves (MHz range) |
| Sensory Experience | Tingling / buzz | Gentle hum / no shock |
| Depth of Effect | Surface nerve trunk | Deep afferent fibers to brainstem |
| Precision | User-dependent electrode placement | Self-aligning ear interface |
| Evidence Level | Internal pilot data | Peer-reviewed RCT (JMIR 2025) |
| Comfort & Adherence | Moderate – some users feel sting | High – no pain |
Pulsetto uses the electrical-current paradigm pioneered by GammaCore and Parasym - proven safe but often limited by skin impedance and user comfort.
ZenBud uses acoustic coupling, stimulating the same neural pathways mechanically rather than electrically, resulting in deeper reach and greater consistency.
5. Cervical vs Auricular Stimulation
Pulsetto targets the neck, where the vagus nerve runs deep alongside major blood vessels. While effective for many, cervical stimulation can vary based on anatomy and electrode placement.
ZenBud targets the ear, specifically the auricular branch. Though smaller, this nerve connects directly to the nucleus tractus solitarius (NTS) - the parasympathetic control hub in the brainstem.
- Cervical = broader influence (on heart and organs).
- Auricular = precise and safe for daily use.
Both work, but one favors ease of access while the other favors exact targeting.
6. Comfort and Consistency
User comfort determines whether a device becomes a habit or a drawer decoration.
Pulsetto: electrical stimulation can produce tingling or twitching, and results depend on electrode angle, pressure, and hydration. For many, it’s tolerable; for some, it’s distracting.
ZenBud: ultrasound stimulation is imperceptible - users typically describe a calm spreading sensation rather than a shock. The device’s gel-free silicone interface ensures consistent coupling and effortless daily use.
That difference translates to higher adherence - which, in real life, often matters more than any single physiological metric.
7. Clinical Grounding vs Market Momentum
Pulsetto has excelled at communication - strong branding, clear use cases, and a simple app experience that made “vagus nerve stimulation” part of everyday vocabulary.
ZenBud, conversely, has focused on clinical grounding before marketing. Its data are peer-reviewed; its technology is built on published ultrasound-neuromodulation research led by Dr. Marcus Kaiser and others.
If Pulsetto’s superpower is reach, ZenBud’s is replicability. One popularized the category; the other defined its next benchmark.
8. Design Philosophy: Habit vs Hardware
| Theme | Pulsetto | ZenBud |
|---|---|---|
| Goal | Create daily stress-relief habit via app engagement | Deliver precise neuromodulation with minimal friction |
| Form Factor | Adjustable neck band + gel pads | Ear-based headset with soft silicone pads |
| User Journey | Guided programs and tracking | Five-minute silent sessions |
| Business Model | App-subscription ecosystem | Durable one-time hardware purchase |
| Core Ethic | Behavioral engagement | Biophysical efficacy |
Pulsetto is a wellness companion; ZenBud is a nerve-modulation instrument disguised as a wearable. Different philosophies - same mission: empowerment through self-regulation.
9. The Outcomes
Preliminary Pulsetto data show improved HRV and reduced perceived stress after two weeks of use, consistent with prior electrical-VNS literature (~10–15 % improvement range).
ZenBud’s JMIR Neuro data show 78.6 % remission in clinical anxiety - roughly 5–7× greater effect size.
That gap reflects not marketing, but mechanism fidelity. Ultrasound engages deeper fibers and higher-order feedback loops within the autonomic network - reaching the brainstem directly, not just the skin receptors above it.
10. The Road Ahead
Pulsetto proved something crucial: people are ready to take nervous-system care into their own hands. ZenBud proves something equally crucial: the science is ready to meet them there.
In the coming years, expect convergence:
- Pulsetto-style usability + ZenBud-level precision = next-generation adaptive neuromodulation.
- App intelligence paired with anatomical targeting.
- A nervous-system gym for the masses.
Until then, Pulsetto remains a fantastic on-ramp - friendly, accessible, and habit-forming. ZenBud is the destination - evidence-based, effortless, and built to restore the system itself.
Different waves. One purpose: a calmer human future.